(19)
(11) EP 1 187 633 A1

(12)

(43) Date of publication:
20.03.2002 Bulletin 2002/12

(21) Application number: 00931923.7

(22) Date of filing: 07.04.2000
(51) International Patent Classification (IPC)7A61K 39/395, C07K 16/00
(86) International application number:
PCT/US0009/255
(87) International publication number:
WO 0061/186 (19.10.2000 Gazette 2000/42)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.04.1999 US 128713 P

(71) Applicants:
  • ARCH DEVELOPMENT CORPORATION
    Chicago, Illinois 60637 (US)
  • DANA-FARBER CANCER INSTITUTE, INC.
    Boston, MA 02115 (US)

(72) Inventors:
  • WEICHSELBAUM, Ralph, R.
    Chicago, IL 60614 (US)
  • KUFE, Donald, W.
    Wellesley, MA 02181 (US)

(74) Representative: Grund, Martin, Dr. et al
Dr. Volker Vossius,Patentanwaltskanzlei,Holbeinstrasse 5
81679 München
81679 München (DE)

   


(54) USE OF ANTI-VEGF ANTIBODY TO ENHANCE RADIATION IN CANCER THERAPY